Further observations on the therapy with a beta-stimulating agent in Raynaud's phenomenon.
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D010991:Plethysmography; D011928:Raynaud Disease / Q000188:drug therapy*; D012881:Skin Temperature; D013726:Terbutaline / Q000627:therapeutic use*; D013997:Time Factors
D013726:Terbutaline